CA Stock MarketDetailed Quotes

XRX XORTX Therapeutics Inc

Watchlist
  • 4.800
  • 0.0000.00%
15min DelayMarket Closed Nov 4 16:00 ET
59.00MMarket Cap-13.64P/E (TTM)

XORTX Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
(Q3)Sep 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-344.41%-861.99K
41.11%-1.17M
-191.85%-728.4K
1,597.51%1.57M
-1,038.59%-119.64K
-383.14%-193.96K
-1,593.92%-1.99M
83.95%-249.58K
15.62%-104.93K
106.40%12.75K
Net income from continuing operations
41.55%-218.45K
-6,440.44%-2.17M
-104.04%-1.28M
-138.95%-452.73K
-222.26%-424.91K
-140.47%-373.74K
78.26%-33.23K
83.33%-629.58K
-28.48%-189.47K
57.03%-131.85K
Operating gains losses
-1,770.32%-664.86K
1,009.34%1.32M
-363.66%-89.81K
-326.58%-28.23K
930.09%43.4K
198.27%39.8K
-1,173.31%-144.79K
172.59%34.06K
138.35%12.46K
-147.25%-5.23K
Depreciation and amortization
-14.17%4.37K
-15.96%4.24K
2.71%20.44K
2.62%5.14K
2.92%5.15K
2.70%5.1K
2.60%5.05K
3.02%19.9K
1.77%5.01K
2.77%5.01K
Asset impairment expenditure
----
----
--64.56K
----
----
----
----
--0
----
----
Remuneration paid in stock
----
----
---95.49K
----
----
----
----
--0
----
----
Remuneration paid in stock
-52.27%90.45K
2,917.09%202.99K
1,015.03%293.44K
-21.12%6.75K
768.31%90.44K
1,278.16%189.52K
205.03%6.73K
-90.43%26.32K
-1.12%8.56K
-45.13%10.42K
Other non cashItems
--0
17,714.73%75K
-48.35%846
--0
--0
4.68%425
6.05%421
-99.94%1.64K
-98.87%420
4.53%415
Change In working capital
-33.48%-73.51K
67.31%-595.07K
21.52%362.21K
3,465.36%2.07M
24.10%166.27K
-166.51%-55.07K
-7,951.94%-1.82M
144.22%298.08K
1,129.02%58.1K
85.10%133.99K
-Change in receivables
----
36.28%-89.66K
-390.76%-43K
698.77%42.99K
----
----
-17,450.31%-140.71K
173.72%14.79K
338.04%5.38K
-243.78%-113.62K
-Change in prepaid assets
69.91%-63.99K
--0
----
----
--212.62K
---212.62K
---1.61M
----
----
--0
-Change in payables and accrued expense
-689.01%-99.18K
-252.73%-505.41K
14.70%405.21K
300.95%492.02K
-83.99%39.64K
142.73%16.84K
-740.47%-143.29K
1,699.17%353.29K
1,656.07%122.71K
3,830.19%247.61K
-Change in other working capital
----
----
----
----
--0
--0
--70K
---70K
----
----
Cash from discontinued investing activities
Operating cash flow
-344.41%-861.99K
41.11%-1.17M
-191.85%-728.4K
1,597.51%1.57M
-1,038.59%-119.64K
-383.14%-193.96K
-1,593.92%-1.99M
83.95%-249.58K
15.62%-104.93K
106.40%12.75K
Investing cash flow
Cash flow from continuing investing activities
-184.86%-10.28K
94.28%-186
-103.92%-14.35K
-1,732.26%-2.84K
-26.16%-4.65K
-12.97%-3.61K
-3.25K
95.45%-7.04K
96.09%-155
58.49%-3.69K
Net intangibles purchas and sale
-184.86%-10.28K
94.28%-186
-103.92%-14.35K
-1,732.26%-2.84K
-26.16%-4.65K
-12.97%-3.61K
---3.25K
82.87%-7.04K
96.09%-155
90.06%-3.69K
Cash from discontinued investing activities
Investing cash flow
-184.86%-10.28K
94.28%-186
-103.92%-14.35K
-1,732.26%-2.84K
-26.16%-4.65K
-12.97%-3.61K
---3.25K
95.45%-7.04K
96.09%-155
58.49%-3.69K
Financing cash flow
Cash flow from continuing financing activities
-22.97K
188.42%7.04M
1,449.32%855.41K
-2,973.14%-1.59M
0
0
2.44M
-97.11%55.21K
55.21K
0
Net common stock issuance
--0
146.21%6.12M
--900K
---1.59M
--0
--0
--2.49M
--0
--0
--0
Proceeds from stock option exercised by employees
--0
--1.01M
----
----
----
----
--0
----
----
----
Net other financing activities
---22.97K
-109.12%-93.25K
-180.77%-44.59K
--0
--0
--0
---44.59K
212.39%55.21K
----
----
Cash from discontinued financing activities
Financing cash flow
---22.97K
188.42%7.04M
1,449.32%855.41K
-2,973.14%-1.59M
--0
--0
--2.44M
-97.11%55.21K
--55.21K
--0
Net cash flow
Beginning cash position
1,082.83%6.04M
192.20%171.27K
-77.46%58.61K
74.30%189.09K
215.19%313.39K
257.89%510.96K
-77.46%58.61K
319.80%260.02K
-72.06%108.49K
-83.33%99.43K
Current changes in cash
-353.12%-895.23K
1,198.24%5.87M
155.94%112.66K
64.27%-17.82K
-1,472.22%-124.3K
-355.87%-197.57K
485.79%452.34K
-201.68%-201.41K
61.13%-49.87K
104.35%9.06K
End cash Position
1,542.86%5.15M
1,082.83%6.04M
192.20%171.27K
192.20%171.27K
74.30%189.09K
215.19%313.39K
257.89%510.96K
-77.46%58.61K
-77.46%58.61K
-72.06%108.49K
Free cash from
-341.50%-872.27K
41.20%-1.17M
-189.44%-742.75K
1,592.60%1.57M
-1,472.22%-124.3K
-355.87%-197.57K
-1,596.69%-1.99M
83.93%-256.62K
18.10%-105.09K
104.35%9.06K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019(Q3)Sep 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -344.41%-861.99K41.11%-1.17M-191.85%-728.4K1,597.51%1.57M-1,038.59%-119.64K-383.14%-193.96K-1,593.92%-1.99M83.95%-249.58K15.62%-104.93K106.40%12.75K
Net income from continuing operations 41.55%-218.45K-6,440.44%-2.17M-104.04%-1.28M-138.95%-452.73K-222.26%-424.91K-140.47%-373.74K78.26%-33.23K83.33%-629.58K-28.48%-189.47K57.03%-131.85K
Operating gains losses -1,770.32%-664.86K1,009.34%1.32M-363.66%-89.81K-326.58%-28.23K930.09%43.4K198.27%39.8K-1,173.31%-144.79K172.59%34.06K138.35%12.46K-147.25%-5.23K
Depreciation and amortization -14.17%4.37K-15.96%4.24K2.71%20.44K2.62%5.14K2.92%5.15K2.70%5.1K2.60%5.05K3.02%19.9K1.77%5.01K2.77%5.01K
Asset impairment expenditure ----------64.56K------------------0--------
Remuneration paid in stock -----------95.49K------------------0--------
Remuneration paid in stock -52.27%90.45K2,917.09%202.99K1,015.03%293.44K-21.12%6.75K768.31%90.44K1,278.16%189.52K205.03%6.73K-90.43%26.32K-1.12%8.56K-45.13%10.42K
Other non cashItems --017,714.73%75K-48.35%846--0--04.68%4256.05%421-99.94%1.64K-98.87%4204.53%415
Change In working capital -33.48%-73.51K67.31%-595.07K21.52%362.21K3,465.36%2.07M24.10%166.27K-166.51%-55.07K-7,951.94%-1.82M144.22%298.08K1,129.02%58.1K85.10%133.99K
-Change in receivables ----36.28%-89.66K-390.76%-43K698.77%42.99K---------17,450.31%-140.71K173.72%14.79K338.04%5.38K-243.78%-113.62K
-Change in prepaid assets 69.91%-63.99K--0----------212.62K---212.62K---1.61M----------0
-Change in payables and accrued expense -689.01%-99.18K-252.73%-505.41K14.70%405.21K300.95%492.02K-83.99%39.64K142.73%16.84K-740.47%-143.29K1,699.17%353.29K1,656.07%122.71K3,830.19%247.61K
-Change in other working capital ------------------0--0--70K---70K--------
Cash from discontinued investing activities
Operating cash flow -344.41%-861.99K41.11%-1.17M-191.85%-728.4K1,597.51%1.57M-1,038.59%-119.64K-383.14%-193.96K-1,593.92%-1.99M83.95%-249.58K15.62%-104.93K106.40%12.75K
Investing cash flow
Cash flow from continuing investing activities -184.86%-10.28K94.28%-186-103.92%-14.35K-1,732.26%-2.84K-26.16%-4.65K-12.97%-3.61K-3.25K95.45%-7.04K96.09%-15558.49%-3.69K
Net intangibles purchas and sale -184.86%-10.28K94.28%-186-103.92%-14.35K-1,732.26%-2.84K-26.16%-4.65K-12.97%-3.61K---3.25K82.87%-7.04K96.09%-15590.06%-3.69K
Cash from discontinued investing activities
Investing cash flow -184.86%-10.28K94.28%-186-103.92%-14.35K-1,732.26%-2.84K-26.16%-4.65K-12.97%-3.61K---3.25K95.45%-7.04K96.09%-15558.49%-3.69K
Financing cash flow
Cash flow from continuing financing activities -22.97K188.42%7.04M1,449.32%855.41K-2,973.14%-1.59M002.44M-97.11%55.21K55.21K0
Net common stock issuance --0146.21%6.12M--900K---1.59M--0--0--2.49M--0--0--0
Proceeds from stock option exercised by employees --0--1.01M------------------0------------
Net other financing activities ---22.97K-109.12%-93.25K-180.77%-44.59K--0--0--0---44.59K212.39%55.21K--------
Cash from discontinued financing activities
Financing cash flow ---22.97K188.42%7.04M1,449.32%855.41K-2,973.14%-1.59M--0--0--2.44M-97.11%55.21K--55.21K--0
Net cash flow
Beginning cash position 1,082.83%6.04M192.20%171.27K-77.46%58.61K74.30%189.09K215.19%313.39K257.89%510.96K-77.46%58.61K319.80%260.02K-72.06%108.49K-83.33%99.43K
Current changes in cash -353.12%-895.23K1,198.24%5.87M155.94%112.66K64.27%-17.82K-1,472.22%-124.3K-355.87%-197.57K485.79%452.34K-201.68%-201.41K61.13%-49.87K104.35%9.06K
End cash Position 1,542.86%5.15M1,082.83%6.04M192.20%171.27K192.20%171.27K74.30%189.09K215.19%313.39K257.89%510.96K-77.46%58.61K-77.46%58.61K-72.06%108.49K
Free cash from -341.50%-872.27K41.20%-1.17M-189.44%-742.75K1,592.60%1.57M-1,472.22%-124.3K-355.87%-197.57K-1,596.69%-1.99M83.93%-256.62K18.10%-105.09K104.35%9.06K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.